Navigation Links
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
Date:8/7/2009

marketing 9,396,129 7,687,892 14,607,631 12,717,600 Advertising 7,779,936 7,452,231 13,347,293 11,846,572 General and administrative 4,315,714 5,253,274 8,881,357 9,165,957 Depreciation and amortization 1,850,274 1,010,461 3,709,189 1,987,671 Total operating expenses 23,342,053 21,403,858 40,545,470 35,717,800 INCOME FROM OPERATIONS 18,285,061 18,677,700 29,498,496 30,654,720 EQUITY IN EARNINGS (LOSS) FROM UNCONSOLIDATED ENTITIES (173,258) (640,008) 264,536 (641,067) INTEREST INCOME (EXPENSE), NET (1,620,069) (30,616) (3,199,338) (13,769) OTHER INCOME (EXPENSE), NET (16,329) (255,770) (114,938) (356,502) INCOME BEFORE INCOME TAXES 16,475,405 17,751,306 26,448,756 29,643,382 INCOME TAXES 3,369,107 3,891,614 5,472,406 6,361,562 NET INCOME 13,106,298 13,859,692 20,976,350 23,281,820 NET INCOME ATTRIBUTABLE TO NON- CONTROLLING INTEREST 123,068 -- 119,517 -- NET INCOME ATTRIBUTABLE TO CONTROLLING INTEREST 13,229,366 13,859,692 21,095,867 23,281,820 OTHER COMPREHENSIVE INCOME Foreign currency translation gain, net of tax 46,316 5,154,761 424,782 12,089,196 TOTAL OTHER COMPREHENSIVE INCOME, NET OF TAX 46,316 5,154,761 424,782 12,089,196 COMPREHENSIVE INCOME $13,275,682 $19,014,453 $21,520,649 $35,371,016 NET INCOME PER SHARE BASIC $0.18 $0.18 $0.28 $0.30 DILUTED $0.17 $0.18 $0.28 $0.30 WEIGHTED AVERAGE NUMBER O
'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... LONDON , Aug. 27, 2014 ... The Graphene Opportunity - A Rational ... Is Graphene The New Nanotech? A similar ... predictions of applications ranging from microelectronics to water ... today announced the availability of the Graphene Opportunity ...
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... the "Global Enzyme for Pulp & Paper Industry ... The Global Enzyme for Pulp & Paper Industry ... the current state of the global enzyme for pulp ... basic overview of the industry including definitions, classifications, applications ...
(Date:8/27/2014)...  ARCH Venture Partners, one of the largest ... of seed and early-stage advanced technology companies, today ... more than $400 million in subscriptions. ARCH Venture ... by more than $150 million. "The ... potential of our approach to finding and funding ...
(Date:8/27/2014)... Beach County, Florida (PRWEB) August 27, 2014 ... Company Inc. (SCI) is announcing the creation of ... priority is to take the SCI’s philosophy of ... the company’s research and development actions are based ... , This new Scientific Advisory Board provides a ...
Breaking Biology Technology:The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Global Enzyme for Pulp & Paper Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3
... 14 Transgenomic, Inc. (the,"Company") (OTC Bulletin Board: TBIO) ... 2007. The Company,s financial results are,presented in the tables ... reported a net profit of $0.2 million or $0.00 ... to a net loss of $0.4 million or,$0.01 per ...
... Board of Directors,meeting held today, the Directors declared ... dividend is payable on September 14, 2007 to,shareholders ... Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and ... and kits,are used in scientific and genomic research, ...
... Quarter Last Year, - 17 Percent Quarter-to-Quarter Revenue Gain Evidences Start of Turnaround ... for Core Business ... - DelSite Signs Additional Agreements, IRVING, Texas, Aug. 14 Carrington,Laboratories, ... $5.6 million, compared to $6.5 million in the year ago,period. The revenue in the ...
Cached Biology Technology:Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Carrington Reports Second Quarter 2007 Results 2Carrington Reports Second Quarter 2007 Results 3Carrington Reports Second Quarter 2007 Results 4Carrington Reports Second Quarter 2007 Results 5Carrington Reports Second Quarter 2007 Results 6Carrington Reports Second Quarter 2007 Results 7
(Date:8/28/2014)... free mobile app called TX Invasives is now available ... University of Texas at Austin for identifying harmful non-native ... Invasive species in the United States cause about $137 ... destroy agricultural crops, clog waterways, kill native plants and ... Invasives app for reporting where invasive species occur, we,re ...
(Date:8/28/2014)... (ESA) is pleased to announce the selection of Dr. ... Honorary Membership acknowledges those who have served ESA for ... affairs of the Society that has reached an extraordinary ... ESA Governing Board and then voted on by the ... Awards Ceremony at Entomology 2014, ESA,s Annual Meeting in ...
(Date:8/28/2014)... handful of bacterial culprits that may drive inflammatory bowel ... using patients, own intestinal immune responses as a guide. ... journal Cell . , Trillions of bacteria exist ... role in the development and progression of IBD. Yet ... species affect a person,s susceptibility to IBD and its ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Yale study identifies possible bacterial drivers of IBD 2
... one scratchy tune learned in its youth, which it ... occasionally, the finch might improvise, experimenting with a slower, ... studying the finch now say the improvisation arises from ... section of the forebrain that seems to generate the ...
... in St. Louis have discovered an entirely new cellular ... plant flowering and DNA methylation, a key chemical process ... by Craig Pikaard, Ph, D., Washington University professor of ... kind of RNA polymerase found only in plants and ...
... (CLL) is an incurable disease in which cells in the ... become abnormal and malignant (leukemic). The progression of the disease ... regarding the rate of production of CLL cells, and the ... believed that CLL was a static disease of long-lived lymphocytes ...
Cached Biology News:Bird Brains Show How Trial and Error May Contribute to Learning 2Bird Brains Show How Trial and Error May Contribute to Learning 3New RNA polymerase discovered in plants 2New RNA polymerase discovered in plants 3The very unexpected life and death of a leukemic cell 2